Stage IIA Gallbladder Cancer AJCC v8
specificStage IIA includes: T2a, N0, M0. T2a: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)
36
Centers
36
Active Trials
—
Cancer Funding
Top Centers for Stage IIA Gallbladder Cancer AJCC v8(36)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.4 |
| 2 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 51.4 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 51.4 |
| 4 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 51.4 |
| 5 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 51.4 |
| 6 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 51.4 |
| 7 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 51.4 |
| 8 | NCI Comprehensive Active Research Program | 51.4 |
| 9 | NCI Comprehensive Active Research Program | 51.4 |
| 10 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 51.4 |
| 11 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.4 |
| 12 | NCI Comprehensive Active Research Program | 51.4 |
| 13 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 51.4 |
| 14 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.4 |
| 15 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 51.4 |
| 16 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.4 |
| 17 | NCI Clinical Active Research Program | 51.4 |
| 18 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 51.4 |
| 19 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 51.4 |
| 20 | UMass Memorial Health Cancer CenterWorcester, MA Active Research Program | 51.4 |
| 21 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 51.4 |
| 22 | Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive Active Research Program | 51.4 |
| 23 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 51.4 |
| 24 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 51.4 |
| 25 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 51.4 |
| 26 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.4 |
| 27 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 51.4 |
| 28 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 51.4 |
| 29 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.4 |
| 30 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 51.4 |
| 31 | Penn State Cancer InstituteHershey, PA Active Research Program | 51.4 |
| 32 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.4 |
| 33 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 51.4 |
| 34 | UofL James Graham Brown Cancer CenterLouisville, KY Active Research Program | 51.4 |
| 35 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 51.4 |
| 36 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 51.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →